Skip to main content
. 2020 May 5;18:103. doi: 10.1186/s12916-020-01564-3

Fig. 5.

Fig. 5

Overview of the evidence base for beta-blockers versus control in cardiovascular health.a Compared to other medications. b In trials with a low risk of bias. c In contemporary trials with majority undergoing reperfusion. AF, atrial fibrillation; CAD, coronary artery disease; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; MI, myocardial infarction; RR, risk ratio